Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia (Q44355510)
Jump to navigation
Jump to search
scientific article published in May 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia |
scientific article published in May 2012 |
Statements
1 reference
Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia (English)
1 reference
J N Mahlangu
1 reference
M J Coetzee
1 reference
M Laffan
1 reference
J Windyga
1 reference
T T Yee
1 reference
J Schroeder
1 reference
J Haaning
1 reference
J E Siegel
1 reference
G Lemm
1 reference
1 May 2012
1 reference
1 reference
10
1 reference
5
1 reference
773-780
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference